85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

12 trials found

diseases per page:

Showing 1 to 10 of 12 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-024211-13-DE (EUCTR)	20/07/2011	12/04/2011	Study to evaluate if macitentanis safe and tolerable enough to be used for treatment of idiopathic p ...	Long term, single-arm, open-label extension study of the MUSIC study to assess the safety and tolera ...	Patients with Idiopathic Pulmonary Fibrosis MedDRA version: 13.1;Level: PT;Classification code 10021 ...	Product Name: Macitentan Product Code: ACT-064992 INN or Proposed INN: macitentan	ACTELION Pharmaceuticals Ltd.	NULL	Not Recruiting			Female: yes Male: yes	178		Germany;Canada;Turkey;Spain;United States;Sweden;South Africa;Australia;Israel
2	NCT01346930 (ClinicalTrials.gov)	July 2011	2/5/2011	Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis	Long Term, Single-arm, Open-label Extension Study of the MUSIC Study to Assess the Safety and Tolera ...	Idiopathic Pulmonary Fibrosis	Drug: Macitentan	Actelion	NULL	Withdrawn	18 Years	N/A	Both	0	Phase 2	NULL
3	EUCTR2010-024211-13-ES (EUCTR)	27/06/2011	10/11/2011	Study to evaluate if macitentanis safe and tolerable enough to be usedfor treatment of idiopathic pu ...	Long term, single-arm, open-label extension study of the MUSIC study toassess the safety and tolerab ...	Patients with Idiopathic Pulmonary Fibrosis MedDRA version: 14.0;Level: PT;Classification code 10021 ...	Product Name: Macitentan Product Code: ACT-064992 INN or Proposed INN: macitentan	ACTELION Pharmaceuticals Ltd.	NULL	Not Recruiting			Female: yes Male: yes	178	Phase 2	United States;Slovenia;Canada;Spain;Turkey;Australia;South Africa;Israel;Germany;Sweden
4	EUCTR2010-024211-13-SI (EUCTR)	13/06/2011	11/07/2011	Study to evaluate if macitentanis safe and tolerable enough to be used for treatment of idiopathic p ...	Long term, single-arm, open-label extension study of the MUSIC study to assess the safety and tolera ...	Patients with Idiopathic Pulmonary Fibrosis MedDRA version: 14.0;Level: PT;Classification code 10021 ...	Product Name: Macitentan Product Code: ACT-064992 INN or Proposed INN: macitentan	ACTELION Pharmaceuticals Ltd.	NULL	Not Recruiting			Female: yes Male: yes	178	Phase 2	United States;Slovenia;Canada;Spain;Turkey;Australia;South Africa;Israel;Germany;Sweden
5	EUCTR2010-024211-13-SE (EUCTR)	26/05/2011	05/04/2011	Study to evaluate if macitentanis safe and tolerable enough to be used for treatment of idiopathic p ...	Long term, single-arm, open-label extension study of the MUSIC study to assess the safety and tolera ...	Patients with Idiopathic Pulmonary Fibrosis MedDRA version: 13.1;Level: PT;Classification code 10021 ...	Product Name: Macitentan Product Code: ACT-064992 INN or Proposed INN: macitentan	ACTELION Pharmaceuticals Ltd.	NULL	Not Recruiting			Female: yes Male: yes	178	Phase 2	United States;Slovenia;Canada;Spain;Turkey;Australia;South Africa;Israel;Germany;Sweden
6	EUCTR2008-006054-17-IT (EUCTR)	26/01/2010	22/10/2009	A double-blind, randomized, placebo-controlled, multicenter, parallel group study to evaluate the ef ...	A double-blind, randomized, placebo-controlled, multicenter, parallel group study to evaluate the ef ...	Idiopathic Pulmonary Fibrosis MedDRA version: 9.1;Level: LLT;Classification code 10021240	Product Name: Macitentan Product Code: ACT-064992 INN or Proposed INN: Macitentan	Actelion Pharamceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	156		Germany;Slovenia;France;Spain;Italy;Sweden
7	EUCTR2008-006054-17-SE (EUCTR)	12/08/2009	25/06/2009	A double-blind, randomized, placebo-controlled, multicenter, parallel group study to evaluate the ef ...	A double-blind, randomized, placebo-controlled, multicenter, parallel group study to evaluate the ef ...	To evaluate the efficacy, safety, and tolerabilitiy of macitentanin patients with idiopathic pulmona ...	Product Name: macitentan Product Code: ACT-064992 INN or Proposed INN: macitentan	Actelion Pharmaceuticals Ltd.	NULL	Not Recruiting			Female: yes Male: yes	156		Germany;Slovenia;France;Spain;Italy;Sweden
8	EUCTR2008-006054-17-ES (EUCTR)	20/05/2009	01/04/2009	Estudio multicéntrico, aleatorizado, de grupos paralelos, doble ciego, controlado con placebo para e ...	Estudio multicéntrico, aleatorizado, de grupos paralelos, doble ciego, controlado con placebo para e ...	Evaluar la eficacia, seguridad y tolerabilidad de Macitentanen pacientes con Fibrosis Pulmonar Idiop ...	Product Name: Macitentan Product Code: ACT-064992 INN or Proposed INN: Macitentan	Actelion Pharmaceuticals Ltd.	NULL	Not Recruiting			Female: yes Male: yes	156	Phase 2	France;Slovenia;Spain;Germany;Italy;Sweden
9	NCT00903331 (ClinicalTrials.gov)	May 2009	14/5/2009	Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study	A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Ef ...	Idiopathic Pulmonary Fibrosis	Drug: ACT-064992 (macitentan);Drug: Placebo	Actelion	NULL	Completed	18 Years	N/A	All	178	Phase 2	United States;Australia;Canada;France;Germany;Israel;Italy;Slovenia;South Africa;Spain;Sweden;Turkey ...
10	EUCTR2008-006054-17-FR (EUCTR)	29/04/2009	25/03/2009	MUSIC: MacitentanUSe in an Idiopathic pulmonary fibrosis Clinical studyA double-blind, randomized, p ...	MUSIC: MacitentanUSe in an Idiopathic pulmonary fibrosis Clinical studyA double-blind, randomized, p ...	to evaluate the efficacy, safety, and tolerability of macitentanin patients with idiopathic pulmonar ...	Product Name: ACT-064992 Product Code: ACT-064992 INN or Proposed INN: MACITENTAN	Actelion Pharmaceuticals Ltd.	NULL	Not Recruiting			Female: yes Male: yes	156	Phase 2	France;Slovenia;Spain;Germany;Italy;Sweden

First Previous1 2Next Last